These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25332317)

  • 1. Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
    Hwang JH; Chin HJ; Kim S; Kim DK; Kim S; Park JH; Shin SJ; Lee SH; Choi BS; Lim CS
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2059-69. PubMed ID: 25332317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of urine urea nitrogen and protein intake adjusted by using the estimated urine creatinine excretion rate on the antiproteinuric effect of angiotensin II type I receptor blockers.
    Chin HJ; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Kim S; Lim CS
    Nutrition; 2015; 31(11-12):1333-8. PubMed ID: 26304595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
    Keyzer CA; de Jong MA; Fenna van Breda G; Vervloet MG; Laverman GD; Hemmelder M; Janssen WM; Lambers Heerspink HJ; Navis G; de Borst MH;
    Nephrol Dial Transplant; 2016 Jul; 31(7):1081-7. PubMed ID: 25744274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
    de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G
    Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low-salt diet increases the estimated net endogenous acid production in nondiabetic chronic kidney disease patients treated with angiotensin receptor blockade.
    Baek SH; Kim S; Kim DK; Park JH; Shin SJ; Lee SH; Choi BS; Chin HJ; Kim S; Lim CS
    Nephron Clin Pract; 2014; 128(3-4):407-13. PubMed ID: 25531146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease.
    Yanagi M; Tamura K; Fujikawa T; Wakui H; Kanaoka T; Ohsawa M; Azushima K; Maeda A; Kobori H; Umemura S
    Hypertens Res; 2013 Mar; 36(3):262-9. PubMed ID: 23154587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.
    Keyzer CA; van Breda GF; Vervloet MG; de Jong MA; Laverman GD; Hemmelder MH; Janssen WM; Lambers Heerspink HJ; Kwakernaak AJ; Bakker SJ; Navis G; de Borst MH;
    J Am Soc Nephrol; 2017 Apr; 28(4):1296-1305. PubMed ID: 27856633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.
    Abe M; Maruyama N; Okada K; Matsumoto S; Matsumoto K; Soma M
    Hypertens Res; 2011 Aug; 34(8):935-41. PubMed ID: 21654755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
    Slagman MC; Waanders F; Hemmelder MH; Woittiez AJ; Janssen WM; Lambers Heerspink HJ; Navis G; Laverman GD;
    BMJ; 2011 Jul; 343():d4366. PubMed ID: 21791491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.
    D'Elia L; Rossi G; Schiano di Cola M; Savino I; Galletti F; Strazzullo P
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1542-52. PubMed ID: 26240299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker.
    Arai K; Morikawa Y; Ubukata N; Sugimoto K
    Hypertens Res; 2020 Nov; 43(11):1204-1213. PubMed ID: 32616846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
    Parvanova A; Trillini M; Podestà MA; Iliev IP; Ruggiero B; Abbate M; Perna A; Peraro F; Diadei O; Rubis N; Gaspari F; Carrara F; Stucchi N; Belviso A; Bossi AC; Trevisan R; Remuzzi G; de Borst M; Ruggenenti P;
    Lancet Diabetes Endocrinol; 2018 Jan; 6(1):27-40. PubMed ID: 29104158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker.
    Furuhashi M; Moniwa N; Mita T; Fuseya T; Ishimura S; Ohno K; Shibata S; Tanaka M; Watanabe Y; Akasaka H; Ohnishi H; Yoshida H; Takizawa H; Saitoh S; Ura N; Shimamoto K; Miura T
    Am J Hypertens; 2015 Jan; 28(1):15-21. PubMed ID: 24842388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support.
    Meuleman Y; Hoekstra T; Dekker FW; Navis G; Vogt L; van der Boog PJM; Bos WJW; van Montfrans GA; van Dijk S;
    Am J Kidney Dis; 2017 May; 69(5):576-586. PubMed ID: 27993433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients.
    Yilmaz R; Akoglu H; Altun B; Yildirim T; Arici M; Erdem Y
    Eur J Clin Nutr; 2012 Nov; 66(11):1214-8. PubMed ID: 22909578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial.
    Iseki K; Arima H; Kohagura K; Komiya I; Ueda S; Tokuyama K; Shiohira Y; Uehara H; Toma S;
    Nephrol Dial Transplant; 2013 Jun; 28(6):1579-89. PubMed ID: 23355629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
    Sakata Y; Shiba N; Takahashi J; Miyata S; Nochioka K; Miura M; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H; ;
    Eur Heart J; 2015 Apr; 36(15):915-23. PubMed ID: 25637937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.
    Kojima M; Okubo S; Mizubayashi R; Isaka N; Machida H; Okamoto S; Hirota H; Takeuchi M; Kato T; Nakatani K; Mizuno O; Miyagawa K; Makino K; Okura T; Dohi Y; Ito M; Kimura G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1802-10. PubMed ID: 23535223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of glomerular and tubulointerstitial injuries by dietary salt reduction with combination therapy of angiotensin II receptor blocker and calcium channel blocker in Dahl salt-sensitive rats.
    Rafiq K; Nishiyama A; Konishi Y; Morikawa T; Kitabayashi C; Kohno M; Masaki T; Mori H; Kobori H; Imanishi M
    PLoS One; 2014; 9(9):e107853. PubMed ID: 25233358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin.
    Ichikawa H; Narita I; Narita M; Tanno T; Yokono Y; Kimura Y; Tanaka M; Osanai T; Okumura K; Tomita H
    Int Heart J; 2018 Nov; 59(6):1445-1453. PubMed ID: 30369568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.